Johnson Matthey (LON:JMAT)‘s stock had its “sell” rating reiterated by equities research analysts at UBS Group in a note issued to investors on Thursday, investing.thisismoney.co.uk reports.

A number of other research firms also recently weighed in on JMAT. Deutsche Bank restated a “buy” rating on shares of Johnson Matthey in a report on Monday, July 16th. Liberum Capital restated a “buy” rating and set a GBX 4,000 ($52.27) price target on shares of Johnson Matthey in a report on Thursday, July 26th. Berenberg Bank restated a “buy” rating and set a GBX 4,300 ($56.19) price target on shares of Johnson Matthey in a report on Tuesday, July 3rd. Finally, Credit Suisse Group restated an “outperform” rating on shares of Johnson Matthey in a report on Thursday, August 23rd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and eight have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of GBX 3,962.50 ($51.78).

Johnson Matthey stock opened at GBX 2,914 ($38.08) on Thursday. Johnson Matthey has a 1-year low of GBX 2,681 ($35.03) and a 1-year high of GBX 3,511 ($45.88).

In other news, insider John Walker bought 12 shares of the stock in a transaction that occurred on Wednesday, October 17th. The shares were acquired at an average cost of GBX 3,093 ($40.42) per share, for a total transaction of £371.16 ($484.99). Also, insider Annette Kelleher sold 985 shares of the firm’s stock in a transaction on Wednesday, August 1st. The shares were sold at an average price of GBX 3,709 ($48.46), for a total transaction of £36,533.65 ($47,737.68). Insiders purchased a total of 36 shares of company stock worth $123,396 over the last quarter.

Johnson Matthey Company Profile

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Read More: Growth Stocks

Analyst Recommendations for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.